LONDON and NEW YORK, Oct. 09, 2024 (GLOBE NEWSWIRE) -- MeiraGTx Holdings (MGTX) plc , a vertically integrated, clinical stage genetic medicine company, today announced a poster presentation at the ...
CRANBURY, N.J., March 25, 2025 /PRNewswire/ -- Palatin Technologies, Inc. (PTN), a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the ...
“MC4R is a key regulator of body weight and is the most common cause of genetic early-onset monogenic obesity. A gene replacement therapy could be transformative for those suffering across the globe.” ...
This article and associated images are based on a poster originally authored by Dhruv Sunil Choudhary and presented at ELRIG Drug Discovery 2025 in affiliation with the University of Westminster. This ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results